Australians have a proud history of achieving globally significant research breakthroughs, including developing penicillin as a medicine for civilian use, the cochlear implant (bionic ear), the discovery that folate consumption during pregnancy reduces spina bifida risk and the invention of a foetal ultrasound, which is now used worldwide.
The Australian biotechnology industry ranked fifth in the latest Scientific American world rankings, based on productivity, intellectual property protection, intensity, enterprise support, education and workforce, foundations, policy and stability. In addition, the strength of the pharmaceuticals industry lies, in large part, in the quality of Australia’s science and medical research, and the country’s reputation for carrying out high-quality clinical trials.
The $20 billion Medical Research Future Fund (MRFF) is supporting Australia’s greatest minds to discover how Australians can live longer and better. The establishment of the MRFF is effectively doubling Australia’s investment in health and medical research and is supported by a National Health and Medical Industry Growth Plan that recognises the importance of the medical technology and pharmaceutical sector.
Professor Ian Frazer is a Companion of the Order of Australia (AC, 2012), a former Australian of the Year (2006) and an internationally renowned immunologist whose research led to the development of a vaccine used worldwide against strains of human papillomavirus. He is the chair of the Australian Medical Research Advisory Board that supports the MRFF and President of the Australian Academy of Health and Medical Science.
Venue: Third floor of the Hamilton Building, 128 N. Broad Street. Cohen Boardroom, Pennsylvania Academy of the Fine Arts, 118-128 Broad Street Philadelphia.
Session ID: 565875